IM Nolte, C Wallace, SJ Newhouse, D Waggott, J Fu, N Soranzo, R Gwilliam, P Deloukas, I Savelieva, D Zheng, C Dalageorgou, M Farrall, NJ Samani, J Connell, M Brown, A Dominiczak, M Lathrop, E Zeggini, LV Wain, C Newton-Cheh, M Eijgelsheim, K Rice, PI de Bakker, A Pfeufer, S Sanna, DE Arking, FW Asselbergs, TD Spector, ND Carter, S Jeffery, M Tobin, M Caulfield, H Snieder, AD Paterson, PB Munroe, Y Jamshidi
To identify loci affecting the electrocardiographic QT interval, a measure of cardiac repolarisation associated with risk of ventricular arrhythmias and sudden cardiac death, we conducted a meta-analysis of three genome-wide association studies (GWAS) including 3,558 subjects from the TwinsUK and BRIGHT cohorts in the UK and the DCCT/EDIC cohort from North America. Five loci were significantly associated with QT interval at P<1x10(-6). To validate these findings we performed an in silico comparison with data from two QT consortia: QTSCD (n = 15,842) and QTGEN (n = 13,685). Analysis confirmed the association between common variants near NOS1AP (P = 1.4x10(-83)) and the phospholamban (PLN) gene (P = 1.9x10(-29)). The most associated SNP near NOS1AP (rs12143842) explains 0.82% variance; the SNP near PLN (rs11153730) explains 0.74% variance of QT interval duration. We found no evidence for interaction between these two SNPs (P = 0.99). PLN is a key regulator of cardiac diastolic function and is involved in regulating intracellular calcium cycling, it has only recently been identified as a susceptibility locus for QT interval. These data offer further mechanistic insights into genetic influence on the QT interval which may predispose to life threatening arrhythmias and sudden cardiac death.
PUBMED: 19587794
Find other GeneSets from this publication